Compositions and methods for inhibiting xdh expression
US-2026055414-A1 · Feb 26, 2026 · US
This page is not indexed by search engines while we improve data quality.
Novo Nordisk As — Human Necessities
Novo Nordisk As holds 11 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Novo Nordisk As |
| Technology | Human Necessities |
| Patents in slice | 11 |
| Recent patents in slice | 3 |
| First year | 2015 |
| Last year | 2026 |
Representative patents
Notable publications linking Novo Nordisk As to Human Necessities.
Regulation of activity of rnai molecules
US-2026049309-A1 · Feb 19, 2026 · US
Regulation of activity of rnai molecules
US-2026049309-A1 · Feb 19, 2026 · US
Regulation of activity of rnai molecules
US-2026049309-A1 · Feb 19, 2026 · US
ApoC-II mimetic peptides
US-11827690-B2 · Nov 28, 2023 · US
Recent filings
Latest patents from Novo Nordisk As in Human Necessities.
Compositions and methods for inhibiting xdh expression
US-2026055414-A1 · Feb 26, 2026 · US
Regulation of activity of rnai molecules
US-2026049309-A1 · Feb 19, 2026 · US
Regulation of activity of rnai molecules
US-2026049309-A1 · Feb 19, 2026 · US
Regulation of activity of rnai molecules
US-2026049309-A1 · Feb 19, 2026 · US
ApoC-II mimetic peptides
US-11827690-B2 · Nov 28, 2023 · US
Related pages
Navigate to parent entity pages.